Products billed under this code include Milrinone In Dextrose, Milrinone Lactate, Milrinone Lactate In Dextrose.
Payment limit per 5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Milrinone In Dextrose | Hikma Pharmaceuticals USA Inc. | 00143-9718-10 | 80 | $91.44 |
| Milrinone In Dextrose | Hikma Pharmaceuticals USA Inc. | 00143-9719-10 | 40 | $45.72 |
| Milrinone In Dextrose | Baxter Healthcare Corporation | 00338-6010-48 | 4 | $4.572 |
| Milrinone In Dextrose | Baxter Healthcare Corporation | 00338-6011-37 | 8 | $9.144 |
| Milrinone In Dextrose | Pfizer Inc | 00409-2045-10 | 40 | $45.72 |
| Milrinone In Dextrose | Sagent Pharmaceuticals | 25021-0313-82 | 40 | $45.72 |
| Milrinone In Dextrose | Sagent Pharmaceuticals | 25021-0313-87 | 80 | $91.44 |
| Milrinone In Dextrose | Eugia US LLC | 55150-0287-10 | 40 | $45.72 |
| Milrinone In Dextrose | Eugia US LLC | 55150-0288-10 | 80 | $91.44 |
| Milrinone Lactate | Hikma Pharmaceuticals USA Inc. | 00143-9326-10 | 40 | $45.72 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Milrinone Lactate | Hikma Pharmaceuticals USA Inc. | 00143-9373-10 | 20 | $22.86 |
| Milrinone Lactate | Hikma Pharmaceuticals USA Inc. | 00143-9374-10 | 40 | $45.72 |
| Milrinone Lactate | Hikma Pharmaceuticals USA Inc. | 00143-9708-01 | 10 | $11.43 |
| Milrinone Lactate | Hikma Pharmaceuticals USA Inc. | 00143-9709-10 | 40 | $45.72 |
| Milrinone Lactate | Hikma Pharmaceuticals USA Inc. | 00143-9710-10 | 20 | $22.86 |
| Milrinone Lactate | Pfizer Inc | 00409-0212-01 | 20 | $22.86 |
| Milrinone Lactate | Pfizer Inc | 00409-0212-02 | 40 | $45.72 |
| Milrinone Lactate | Pfizer Inc | 00409-0212-03 | 10 | $11.43 |
| Milrinone Lactate | FreseniUS Kabi USA, LLC | 63323-0617-10 | 20 | $22.86 |
| Milrinone Lactate | FreseniUS Kabi USA, LLC | 63323-0617-20 | 40 | $45.72 |
| Milrinone Lactate | FreseniUS Kabi USA, LLC | 63323-0617-50 | 10 | $11.43 |
| Milrinone Lactate | Caplin Steriles USA Inc. | 65145-0121-10 | 40 | $45.72 |
| Milrinone Lactate | Caplin Steriles USA Inc. | 65145-0122-01 | 10 | $11.43 |
| Milrinone Lactate | Caplin Steriles USA Inc. | 65145-0176-10 | 40 | $45.72 |
| Milrinone Lactate | Somerset Pharma, LLC | 70069-0807-10 | 20 | $22.86 |
| Milrinone Lactate | Somerset Pharma, LLC | 70069-0808-10 | 40 | $45.72 |
| Milrinone Lactate | Somerset Pharma, LLC | 70069-0809-01 | 10 | $11.43 |
| Milrinone Lactate | Meitheal Pharmaceuticals Inc. | 71288-0200-11 | 20 | $22.86 |
| Milrinone Lactate | Meitheal Pharmaceuticals Inc. | 71288-0200-21 | 40 | $45.72 |
| Milrinone Lactate | Meitheal Pharmaceuticals Inc. | 71288-0200-50 | 10 | $11.43 |
| Milrinone Lactate | Armas Pharmaceuticals Inc. | 72485-0501-10 | 20 | $22.86 |
| Milrinone Lactate | Armas Pharmaceuticals Inc. | 72485-0502-10 | 40 | $45.72 |
| Milrinone Lactate | Armas Pharmaceuticals Inc. | 72485-0503-01 | 10 | $11.43 |
| Milrinone Lactate In Dextrose | Somerset Pharma, LLC | 70069-0872-10 | 40 | $45.72 |
| Milrinone Lactate In Dextrose | Somerset Pharma, LLC | 70069-0873-10 | 80 | $91.44 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $1.143 | +$0.045 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted September 17, 2026 |
| 3Q26 | $1.098 | −$0.085 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted September 15, 2026 |
| 2Q26 | $1.183 | −$0.168 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted September 15, 2026 |
| 1Q26 | $1.351 | −$0.103 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted September 15, 2026 |
| 4Q25 | $1.454 | +$0.05 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted September 8, 2026 |
| 3Q25 | $1.404 | −$0.167 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted March 10, 2026 |
| 2Q25 | $1.571 | +$0.26 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted March 10, 2026 |
| 1Q25 | $1.311 | −$0.102 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted December 19, 2025 |
| 4Q24 | $1.413 | +$0.022 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted June 11, 2025 |
| 3Q24 | $1.391 | −$0.16 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted June 11, 2025 |
| 2Q24 | $1.551 | −$0.011 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted March 11, 2025 |
| 1Q24 | $1.562 | −$0.208 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted December 19, 2024 |
| 4Q23 | $1.77 | −$0.104 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted October 10, 2024 |
| 3Q23 | $1.874 | −$0.25 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted June 5, 2024 |
| 2Q23 | $2.124 | +$0.208 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted February 23, 2024 |
| 1Q23 | $1.916 | +$0.13 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted December 6, 2023 |
| 4Q22 | $1.786 | +$0.081 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted June 22, 2023 |
| 3Q22 | $1.705 | +$0.109 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted June 9, 2023 |
| 2Q22 | $1.596 | −$0.017 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted December 14, 2022 |
| 1Q22 | $1.613 | −$0.274 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted June 8, 2022 |
| 4Q21 | $1.887 | −$0.123 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted June 2, 2022 |
| 3Q21 | $2.01 | +$0.002 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted June 2, 2022 |
| 2Q21 | $2.008 | +$0.259 | 5 MG | Inj milrinone lactate / 5 mg | v1, posted March 1, 2022 |
| 1Q21 | $1.749 | – | 5 MG | Inj milrinone lactate / 5 mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
